An ISO 9001:2008 & GMP certified company  | info@arlakbiotech.com  |  +91-9803023099, 7696263636  |  1800-121-6263 (Toll Free) 

APENTRAL-LS


Description

COMPOSITION: – PANTOPRAZOLE+ LEVOSULPRIDE CAP.

M.R.P: – 1700

PACKING: – 10X10

 

MECHANISM OF ACTION: –

APENTRAL-LS is a combination of LEVOSULPRIDE and PANTOPRAZOLE.

Levosulpiride is a substituted benzamide antipsychotic and increases the release of acetylcholine resulting in increased movement of stomach and intestines that blocks the backward flow of the acid in the food pipe.

Whereas, Pantoprazole is a proton pump inhibitor that reduces the amount of acid in stomach and relieves from indigestion and ulcers.

 

INDICATION

APENTRAL-LS (PANTOPRAZOLE+ LEVOSULPRIDE) is indicated for

  • Gastroesophageal reflux disease (GERD),
  • Indigestion,
  • Back flow of acid from stomach,
  • Duodenal and stomach ulcers,
  • Depression,
  • Heartburn,
  • Dyspepsia,
  • Inflammation of the esophagus and other conditions.
Contact Us
close slider